Related Experiment Videos
[Disc sensitivity test of cefuroxime]
The Japanese Journal of Antibiotics
|July 1, 1983
Summary
The single-disc assay reliably estimates cefuroxime susceptibility in bacteria, correlating well with the standard dilution method across various incubation times. This confirms its applicability for rapid and accurate bacterial testing.
Area of Science:
- Microbiology
- Clinical Pharmacy
- Bacterial Susceptibility Testing
Context:
- Cefuroxime is a crucial cephalosporin antibiotic used to treat various bacterial infections.
- Accurate and rapid determination of bacterial susceptibility to antibiotics is vital for effective treatment.
- The single-disc diffusion method is a common, cost-effective technique for assessing antibiotic susceptibility.
Purpose:
- To evaluate the correlation between the minimum inhibitory concentration (MIC) of cefuroxime determined by the 2-fold agar dilution method and the diameter of the inhibition zone obtained by the single-disc diffusion method.
- To assess the applicability of the single-disc assay for cefuroxime susceptibility testing under different incubation conditions, including rapid assays.
Summary:
- The study tested 124 bacterial strains from 28 species/subspecies against cefuroxime using both agar dilution and single-disc methods.
- A significant correlation was observed between MIC values and inhibition zone diameters across conventional (16-hour), delayed (24-hour), and rapid (3-6 hour) incubation periods.
- Regression equations were derived to predict MIC from inhibition zone diameter for each assay type, demonstrating the disc assay's utility.
Impact:
- The findings validate the single-disc assay as a reliable method for determining cefuroxime susceptibility, offering a faster alternative to traditional dilution methods.
- This can lead to quicker clinical decisions regarding antibiotic therapy, potentially improving patient outcomes.
- The established regression equations provide a quantitative basis for interpreting disc diffusion results for cefuroxime.